Screener
Amneal Pharmaceuticals, Inc. AMRX Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s return on invested capital?
- Amneal Pharmaceuticals, Inc. (AMRX) reported return on invested capital of 20.3% in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s return on invested capital increased by 102.0% year-over-year, from 10.1% to 20.3%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s return on invested capital?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s return on invested capital has grown at a 37.6% compound annual growth rate (CAGR), from 3.2% to 15.7%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Amneal Pharmaceuticals, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude